Sheng, Xi-Nan <br/><br/>
[Clinical study on recombinant human interleukin-2 (Proleukin) in the treatment of metastatic renal cell carcinoma].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Feb 2008 
 - 129-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease Progression<br/>Fatigue--chemically induced<br/>Female<br/>Fever--chemically induced<br/>Follow-Up Studies<br/>Humans<br/>Injections, Subcutaneous<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Lung Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Nephrectomy<br/>Proportional Hazards Models<br/>Recombinant Proteins--administration & dosage<br/>Remission Induction<br/>Survival Rate